Research Triangle Park, NC, United States of America

Bing Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bing Liu. Retrieved from https://idiyas.com/inventor/bing-liu-w09yh3e5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Bing Liu: Innovator in Benzothiazepine Synthesis**

Introduction

Bing Liu is a notable inventor based in Research Triangle Park, North Carolina. With a keen focus on chemical synthesis, he has made significant contributions to the field of pharmaceuticals.

Latest Patents

Bing Liu holds a patent for the synthesis of benzothiazepines. This patent outlines methods for preparing this essential compound, which can play a crucial role in various pharmaceutical applications.

Career Highlights

Bing Liu is currently affiliated with GlaxoSmithKline Intellectual Property Limited, a prestigious company in the pharmaceutical industry. His work at this organization highlights his commitment to advancing drug development and contributing to healthcare solutions.

Collaborations

Throughout his career, Bing Liu has collaborated with talented colleagues, including Jiasheng Guo and Mark B. Mitchell. These collaborations underline the importance of teamwork in the innovation process, allowing for the exchange of ideas and expertise.

Conclusion

Bing Liu's contributions through his patent and collaboration efforts have established him as a key figure in the field of chemical synthesis. His work not only advances scientific knowledge but also has the potential to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…